News

As Bachem is the world’s leading company in developing and manufacturing peptides and oligonucleotides, we receive a lot of interest about our company news and activities.

Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.

 

All Bachem news

  • All
  • Ad-hoc
  • CMC development
  • Commercial APIs
  • Finance
  • Innovation
  • Knowledge
  • News
  • Oligonucleotides
  • Peptides
  • Press
  • Research & specialties
  • Services & capabilities
  • Sustainability
  • Team
  • Trends
Innovation Oligonucleotide Manufacturing
11May2022

Innovation transforming oligonucleotide manufacturing
Bachem set up unique, innovative equipment that optimizes capacity, delivers high-quality products a...
Bachem CDMO EcoVadis Gold Medal
05May2022

Bachem Earns Gold Medal Sustainability Rating from EcoVadis
Bachem received a gold medal rating for sustainability by EcoVadis, an independent leading global pr...
Annual General Meeting Bachem 2022
27Apr2022

Bachem Annual General Meeting 2022
The Annual General Meeting (AGM) 2022 has approved all proposals of the Board of Directors...
Oligonucleotide Synthesizer
26Apr2022

Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances
The annual order volume has the potential to achieve around CHF 100 million....
Generic Interview Pic
01Apr2022

A passion for shaping the future of Bachem: Interview with Diana Rinderle
Diana Rinderle, Site Communications Lead Bachem Bubendorf (CH), spoke with us recently about her exp...
Bachem new facilities for oligonucleotide manufacturing
29Mar2022

Bachem’s new facilities for large-scale oligonucleotide manufacturing
Bachem built facilities and implemented new, innovative solutions for large-scale oligonucleotide AP...

Next events coming up

Full event calendar

Interested in joining at one of our upcoming exhibitions, conferences or webinars? View our full calendar of events.